Lucia Martin-Gisbert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lucia Martin-Gisbert has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Ruano-Ravina
University of Santiago de Compostela
10 shared publications - Mónica Pérez-Ríos
Universidad de Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Spain; Instituto de Investigaciones Sanitarias de Santiago de Compostela, Spain
9 shared publications - Leonor Varela-Lema
University of Santiago de Compostela
8 shared publications - Cristina Candal-Pedreira
Department of Preventive Medicine and Public Health, Universidade de Santiago de Compostela , Santiago de Compostela
7 shared publications - Julia Rey-Brandariz
Department of Preventive Medicine and Public Health, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
6 shared publications - Carla Guerra-Tort
Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
4 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Taylor & Francis in Pulmonology
- Vol. 32 (1)
Evolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016–2022
- 9 November 2026
- Published by Taylor & Francis in Pulmonology
- Vol. 32 (1)
Open AccessEvolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016–2022
- Open Access
- 26 January 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (2) , 316-327
Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
Objective: Spin refers to reporting strategies that highlight the benefits of an experimental treatment or divert attention from nonsignificant primary outcomes. We aimed to assess spin in randomized controlled trials (RCTs) on pharmaceutical efficacy in multiple sclerosis (MS) and explore associated factors. Methods: A systematic literature search was conducted in MedLine (PubMed), EMBASE, and Cochrane using database‐specific thesauri (“Multiple Sclerosis” and “Drug Therapy”) to identify relevant studies. We included multiple sclerosis phase 3 and 4 randomized controlled trials with parallel, superiority designs that were published between 2013 and 2024 reporting nonsignificant primary outcomes. Spin was assessed in title, abstract conclusion, results, discussion, and conclusions. A descriptive analysis was followed by exploratory bivariate logistic regression. Independent variables included trial phase, sample size, drug type, comparison, follow‐up time, registration, Consolidated Standards of Reporting Trials (CONSORT) mention, risk of bias (RoB2), journal quartile, first author affiliation, and conflict of interest. Results: Forty articles met inclusion criteria. Spin appeared in at least one section in 25 articles (62.5%) and in 3 or more in 19 articles (47.5%). The most frequent locations were abstract conclusions, discussion, and conclusions. Spin was significantly associated with smaller sample size (odds ratio [OR] = 7.00, 95% confidence interval [CI] = 1.29–37.91, p = 0.024), non‐Q1 journals (OR = 4.38, 95% CI = 1.03–18.63, p = 0.046), and first author affiliation outside Europe or the United States (OR = 5.09, 95% CI = 1.15–22.62, p = 0.032). Interpretation: Spin is common in MS randomized controlled trials with nonsignificant primary outcomes and may mislead clinical decisions. ANN NEUROL 2026;99:316–327
- 26 January 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (2) , 316-327
Open AccessDistortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
Objective: Spin refers to reporting strategies that highlight the benefits of an experimental treatment or divert attention from nonsignificant primary outcomes. We aimed to assess spin in randomized controlled trials (RCTs) on pharmaceutical efficacy in multiple sclerosis (MS) and explore associated factors. Methods: A systematic literature search was conducted in MedLine (PubMed), EMBASE, and Cochrane using database‐specific thesauri (“Multiple Sclerosis” and “Drug Therapy”) to identify relevant studies. We included multiple sclerosis phase 3 and 4 randomized controlled trials with parallel, superiority designs that were published between 2013 and 2024 reporting nonsignificant primary outcomes. Spin was assessed in title, abstract conclusion, results, discussion, and conclusions. A descriptive analysis was followed by exploratory bivariate logistic regression. Independent variables included trial phase, sample size, drug type, comparison, follow‐up time, registration, Consolidated Standards of Reporting Trials (CONSORT) mention, risk of bias (RoB2), journal quartile, first author affiliation, and conflict of interest. Results: Forty articles met inclusion criteria. Spin appeared in at least one section in 25 articles (62.5%) and in 3 or more in 19 articles (47.5%). The most frequent locations were abstract conclusions, discussion, and conclusions. Spin was significantly associated with smaller sample size (odds ratio [OR] = 7.00, 95% confidence interval [CI] = 1.29–37.91, p = 0.024), non‐Q1 journals (OR = 4.38, 95% CI = 1.03–18.63, p = 0.046), and first author affiliation outside Europe or the United States (OR = 5.09, 95% CI = 1.15–22.62, p = 0.032). Interpretation: Spin is common in MS randomized controlled trials with nonsignificant primary outcomes and may mislead clinical decisions. ANN NEUROL 2026;99:316–327
- Open Access
- 20 November 2025
- Published by Wiley in Obesity Reviews
- Vol. 27 (4) , e70045
Sentinel Networks for the Surveillance of Overweight and Obesity: A Scoping Review
Introduction: To address the high prevalence and significant burden of overweight and obesity, surveillance through sentinel networks should be considered. The aim of this review is to identify the sentinel surveillance networks in relation to overweight and obesity and to describe their characteristics and methodology. Methods: A scoping review was performed using MEDLINE (Ovid and PubMed), Web of Science (WoS), and Scopus, updated until November 2024, and included studies that identified sentinel networks specifically conducting surveillance for overweight and obesity, as well as networks that include these conditions as secondary variables. The main characteristics of each sentinel network and the variables related to overweight and obesity surveillance were recorded. A descriptive analysis was conducted. Results: The search strategy retrieved 467 records, of which 40 fulfilled the inclusion criteria. Ten sentinel networks were identified, located in Europe ( n = 5), Central America ( n = 1), North America ( n = 3), and Oceania ( n = 1). Two were designed specifically for overweight and obesity surveillance. Eight used general practitioners or primary care physicians as their key informants; and of these, four utilized electronic medical records for recording information. One of the three sentinel networks that targeted children conducted surveillance through schools. Conclusion: This review highlights sentinel networks as a valuable option to surveil overweight and obesity and offers a significant step forward towards the subsequent design of new sentinel networks that will address important public health problems such as overweight and obesity.
- 20 November 2025
- Published by Wiley in Obesity Reviews
- Vol. 27 (4) , e70045
Open AccessSentinel Networks for the Surveillance of Overweight and Obesity: A Scoping Review
Introduction: To address the high prevalence and significant burden of overweight and obesity, surveillance through sentinel networks should be considered. The aim of this review is to identify the sentinel surveillance networks in relation to overweight and obesity and to describe their characteristics and methodology. Methods: A scoping review was performed using MEDLINE (Ovid and PubMed), Web of Science (WoS), and Scopus, updated until November 2024, and included studies that identified sentinel networks specifically conducting surveillance for overweight and obesity, as well as networks that include these conditions as secondary variables. The main characteristics of each sentinel network and the variables related to overweight and obesity surveillance were recorded. A descriptive analysis was conducted. Results: The search strategy retrieved 467 records, of which 40 fulfilled the inclusion criteria. Ten sentinel networks were identified, located in Europe ( n = 5), Central America ( n = 1), North America ( n = 3), and Oceania ( n = 1). Two were designed specifically for overweight and obesity surveillance. Eight used general practitioners or primary care physicians as their key informants; and of these, four utilized electronic medical records for recording information. One of the three sentinel networks that targeted children conducted surveillance through schools. Conclusion: This review highlights sentinel networks as a valuable option to surveil overweight and obesity and offers a significant step forward towards the subsequent design of new sentinel networks that will address important public health problems such as overweight and obesity.
- Open Access
- 9 October 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 111, 175-179
Lung cancer mortality attributable to smoking: a multi-scenario analysis with variable lag periods
- 9 October 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 111, 175-179
Open AccessLung cancer mortality attributable to smoking: a multi-scenario analysis with variable lag periods
- Open Access
- 1 May 2025
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 82 (5) , 213-214
Are we underestimating indoor radon exposure in radon priority areas?
- 1 May 2025
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 82 (5) , 213-214
Open AccessAre we underestimating indoor radon exposure in radon priority areas?
- Open Access
- 1 January 2025
- Published by Wiley in Indoor Air
- Vol. 2025 (1)
The Galician Radon Map: Determining Indoor Radon Exposure Through Census Tracts
Indoor radon is a human lung carcinogen. The objective of this research is to describe residential radon distribution in a European region with high geogenic radon potential using cross‐sectional data. This study is also aimed at describing the use of census tracts as a geographical unit in radon maps and describing radon distribution according to floor level. To do this, 6080 radon measurements were carried out by the Galician Radon Laboratory (GRL, https://www.radon.gal ) with alpha track detectors located at each dwelling for at least 3 months. The dwellings measured were the primary residences of volunteer participants. All participants filled out a questionnaire on the dwelling characteristics, and a follow‐up call assured the appropriate return of radon devices to the GRL. A descriptive analysis was performed, including radon concentration distribution per floor level measured and a Galician map of indoor radon using both municipalities and census tracts as geographic units was made. In Galicia, a median radon concentration of 132 Bq/m 3 (interquartile range: 66–239 Bq/m 3 ) and a geometric mean (GM) of 126 Bq/m 3 were observed. Eighteen percent of dwellings exceeded 300 Bq/m 3 . Radon levels vary widely across and within municipalities. The latter can be observed with census tract‐level maps. A height gradient for radon concentration was observed from a GM of 289 Bq/m 3 in cellars to a GM of 89 Bq/m 3 on the fifth floor and above. Remarkably, 14% of dwellings on the second floor exceeded 300 Bq/m 3 , thus challenging the paradigm that indoor radon is only a priority for underground and ground levels in radon priority areas. Galicia is mostly composed of radon priority areas, with high heterogeneity in indoor radon distribution. Census tracts can be used in indoor radon maps as the smallest geographic unit to increase resolution and acknowledge variations within municipalities. In radon priority areas, radon surveillance should include second‐floor levels.
- 1 January 2025
- Published by Wiley in Indoor Air
- Vol. 2025 (1)
Open AccessThe Galician Radon Map: Determining Indoor Radon Exposure Through Census Tracts
Indoor radon is a human lung carcinogen. The objective of this research is to describe residential radon distribution in a European region with high geogenic radon potential using cross‐sectional data. This study is also aimed at describing the use of census tracts as a geographical unit in radon maps and describing radon distribution according to floor level. To do this, 6080 radon measurements were carried out by the Galician Radon Laboratory (GRL, https://www.radon.gal ) with alpha track detectors located at each dwelling for at least 3 months. The dwellings measured were the primary residences of volunteer participants. All participants filled out a questionnaire on the dwelling characteristics, and a follow‐up call assured the appropriate return of radon devices to the GRL. A descriptive analysis was performed, including radon concentration distribution per floor level measured and a Galician map of indoor radon using both municipalities and census tracts as geographic units was made. In Galicia, a median radon concentration of 132 Bq/m 3 (interquartile range: 66–239 Bq/m 3 ) and a geometric mean (GM) of 126 Bq/m 3 were observed. Eighteen percent of dwellings exceeded 300 Bq/m 3 . Radon levels vary widely across and within municipalities. The latter can be observed with census tract‐level maps. A height gradient for radon concentration was observed from a GM of 289 Bq/m 3 in cellars to a GM of 89 Bq/m 3 on the fifth floor and above. Remarkably, 14% of dwellings on the second floor exceeded 300 Bq/m 3 , thus challenging the paradigm that indoor radon is only a priority for underground and ground levels in radon priority areas. Galicia is mostly composed of radon priority areas, with high heterogeneity in indoor radon distribution. Census tracts can be used in indoor radon maps as the smallest geographic unit to increase resolution and acknowledge variations within municipalities. In radon priority areas, radon surveillance should include second‐floor levels.
- Open Access
- 11 October 2024
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 22 (October) , 1-14
Assessment of exposure to secondhand tobacco smoke in Spain: A scoping review
Introduction: There is no consensus on the questions that should be included in questionnaires to properly ascertain exposure to secondhand tobacco smoke (SHS). The objective of this study is to analyze the questions included in studies which have assessed SHS exposure in Spain. Methods: A...
- 11 October 2024
- Published by European Publishing in Tobacco Induced Diseases
- Vol. 22 (October) , 1-14
Open AccessAssessment of exposure to secondhand tobacco smoke in Spain: A scoping review
Introduction: There is no consensus on the questions that should be included in questionnaires to properly ascertain exposure to secondhand tobacco smoke (SHS). The objective of this study is to analyze the questions included in studies which have assessed SHS exposure in Spain. Methods: A...
- 3 July 2024
- Published by Taylor & Francis
- p. 11-28
Indoor radon as a public health problem. Available evidence on radon and its health effects
From a public health perspective, radon exposure concerns human inhalation of radon gas and its decay products within enclosed spaces. This exposure results in ionizing radiation affecting the pulmonary tract and increases the risk of lung cancer, making radon the second leading cause of this disease after smoking. The initial evidence emerged from studies on underground miners, revealing a dose-response relationship between radon exposure and lung cancer. Miner studies were followed by population-based case-control studies where radon was measured in dwellings. Among them, the European case-control pooling study confirmed that even low radon exposures may cause lung cancer. Every increase of 100 Bq/m3 in radon concentration at home increases 16% lung cancer risk, prompting WHO’s indication to not exceed 100 Bq/m3 in homes or workplaces. Furthermore, radon exposure and smoking have a synergic effect on lung cancer risk, and most radon-induced mortality occurs among smokers. Finally, despite the exceptionally large and conclusive evidence on the effects of radon exposure on lung cancer risk, the underlying molecular mechanisms involved remain a subject of ongoing research.
- 3 July 2024
- Published by Taylor & Francis
- p. 11-28
Indoor radon as a public health problem. Available evidence on radon and its health effects
From a public health perspective, radon exposure concerns human inhalation of radon gas and its decay products within enclosed spaces. This exposure results in ionizing radiation affecting the pulmonary tract and increases the risk of lung cancer, making radon the second leading cause of this disease after smoking. The initial evidence emerged from studies on underground miners, revealing a dose-response relationship between radon exposure and lung cancer. Miner studies were followed by population-based case-control studies where radon was measured in dwellings. Among them, the European case-control pooling study confirmed that even low radon exposures may cause lung cancer. Every increase of 100 Bq/m3 in radon concentration at home increases 16% lung cancer risk, prompting WHO’s indication to not exceed 100 Bq/m3 in homes or workplaces. Furthermore, radon exposure and smoking have a synergic effect on lung cancer risk, and most radon-induced mortality occurs among smokers. Finally, despite the exceptionally large and conclusive evidence on the effects of radon exposure on lung cancer risk, the underlying molecular mechanisms involved remain a subject of ongoing research.
- Open Access
- 1 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (2)
Does lung function mediate the role of environmental pollution on overall and cardiovascular disease mortality?
Shareable abstract Lung function and its mediation role on environmental pollution and mortalityhttps://bit.ly/3pdVYJX
- 1 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (2)
Open AccessDoes lung function mediate the role of environmental pollution on overall and cardiovascular disease mortality?
Shareable abstract Lung function and its mediation role on environmental pollution and mortalityhttps://bit.ly/3pdVYJX
- Open Access
- 16 October 2023
- Published by Elsevier in Environmental Research
- Vol. 239, 117305
Radon exposure and its influencing factors across 3,140 workplaces in Spain
- 16 October 2023
- Published by Elsevier in Environmental Research
- Vol. 239, 117305
Open AccessRadon exposure and its influencing factors across 3,140 workplaces in Spain